Increased QT dispersion does not reflect the increased regional variation of cardiac sympathetic nervous activity in hypertrophic cardiomyopathy
- PMID: 11479478
- DOI: 10.1067/mhj.2001.116765
Increased QT dispersion does not reflect the increased regional variation of cardiac sympathetic nervous activity in hypertrophic cardiomyopathy
Abstract
Background: QT dispersion (QTD) reflects regional variation of ventricular repolarization. However, the relationship between QTD and the regional variation of cardiac sympathetic nerve activity in hypertrophic cardiomyopathy (HCM) is not yet elucidated.
Methods: Cardiac sympathetic nerve activity was evaluated in 25 patients with HCM by iodine 123 metaiodobenzylguanidine (MIBG) myocardial scintigraphy. With planar MIBG imaging, heart and mediastinum ratios (H/M) at early (20 minutes) and delayed (3 hours) acquisition and the washout rate (WR) were calculated. Polar maps of left ventricular myocardium were divided into 20 segments. The SD of early uptake (EU-SD), delayed uptake (DU-SD), and WR (WR-SD) in 20 segments as indices of regional variation were calculated. QT intervals were corrected by use of the Bazett formula.
Results: Maximum QTc correlated positively with H/M early, WR, and left ventricular wall thickness (LVWT). Minimum QTc correlated positively with WR and LVWT. Corrected QTD (QTDc) correlated negatively with EU-SD, DU-SD, and WR-SD and positively with the interventricular septal thickness/posterior wall thickness ratio. Stepwise regression analysis revealed that the most powerful determinants for maximum QTc, minimum QTc, and QTDc were WR, LVWT, and EU-SD, respectively.
Conclusions: QTD correlated negatively rather than positively with the regional variability index of cardiac sympathetic nerve activity. These results suggest that increased QTD in patients with HCM may not reflect increased heterogeneity of cardiac sympathetic nerve activity.
Similar articles
-
Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy.J Nucl Med. 2002 Jan;43(1):15-20. J Nucl Med. 2002. PMID: 11801697
-
Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy.J Nucl Med. 2003 Oct;44(10):1612-7. J Nucl Med. 2003. PMID: 14530475 Clinical Trial.
-
Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.J Nucl Med. 2001 Jul;42(7):1017-24. J Nucl Med. 2001. PMID: 11438621
-
Clinical use of metaiodobenzylguanidine imaging in cardiology.Q J Nucl Med. 1995 Dec;39(4 Suppl 1):29-39. Q J Nucl Med. 1995. PMID: 9002746 Review.
-
Cardiac sympathetic activity in hypertrophic cardiomyopathy and Tako-tsubo cardiomyopathy.Clin Transl Imaging. 2015;3(5):379-385. doi: 10.1007/s40336-015-0133-z. Epub 2015 Aug 4. Clin Transl Imaging. 2015. PMID: 26457274 Free PMC article. Review.
Cited by
-
Cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy with malignant ventricular tachyarrhythmias.J Nucl Cardiol. 2003 May-Jun;10(3):304-10. doi: 10.1016/s1071-3581(03)00362-3. J Nucl Cardiol. 2003. PMID: 12794630
-
The relation of QT dispersion and localized QT difference to coronary pathology in a population with unstable coronary artery disease.Ann Noninvasive Electrocardiol. 2003 Jan;8(1):22-9. doi: 10.1046/j.1542-474x.2003.08105.x. Ann Noninvasive Electrocardiol. 2003. PMID: 12848810 Free PMC article.
-
Ventricular Arrhythmias in Patients with Obstructive Sleep Apnea.Curr Cardiol Rev. 2019;15(1):64-74. doi: 10.2174/1573403X14666181012153252. Curr Cardiol Rev. 2019. PMID: 30338742 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical